chr3-48587178-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000094.4(COL7A1):​c.3139+12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 1,612,868 control chromosomes in the GnomAD database, including 107,854 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 18533 hom., cov: 31)
Exomes 𝑓: 0.34 ( 89321 hom. )

Consequence

COL7A1
NM_000094.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.57

Publications

15 publications found
Variant links:
Genes affected
COL7A1 (HGNC:2214): (collagen type VII alpha 1 chain) This gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen. [provided by RefSeq, Jul 2008]
COL7A1 Gene-Disease associations (from GenCC):
  • epidermolysis bullosa with congenital localized absence of skin and deformity of nails
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dystrophic epidermolysis bullosa pruriginosa
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • recessive dystrophic epidermolysis bullosa
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Genomics England PanelApp, Ambry Genetics, G2P, ClinGen
  • generalized dominant dystrophic epidermolysis bullosa
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
  • pretibial dystrophic epidermolysis bullosa
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • transient bullous dermolysis of the newborn
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • acral dystrophic epidermolysis bullosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dystrophic epidermolysis bullosa, nails only
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • recessive dystrophic epidermolysis bullosa inversa
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • recessive dystrophic epidermolysis bullosa-generalized other
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 3-48587178-C-T is Benign according to our data. Variant chr3-48587178-C-T is described in CliVar as Benign. Clinvar id is 255108.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-48587178-C-T is described in CliVar as Benign. Clinvar id is 255108.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-48587178-C-T is described in CliVar as Benign. Clinvar id is 255108.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.759 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL7A1NM_000094.4 linkc.3139+12G>A intron_variant Intron 24 of 118 ENST00000681320.1 NP_000085.1 Q02388-1Q59F16

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL7A1ENST00000681320.1 linkc.3139+12G>A intron_variant Intron 24 of 118 NM_000094.4 ENSP00000506558.1 Q02388-1
COL7A1ENST00000328333.12 linkc.3139+12G>A intron_variant Intron 23 of 117 1 ENSP00000332371.8 Q02388-1

Frequencies

GnomAD3 genomes
AF:
0.449
AC:
68175
AN:
151740
Hom.:
18494
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.766
Gnomad AMI
AF:
0.367
Gnomad AMR
AF:
0.266
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.161
Gnomad SAS
AF:
0.361
Gnomad FIN
AF:
0.455
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.332
Gnomad OTH
AF:
0.395
GnomAD2 exomes
AF:
0.340
AC:
84800
AN:
249290
AF XY:
0.338
show subpopulations
Gnomad AFR exome
AF:
0.773
Gnomad AMR exome
AF:
0.194
Gnomad ASJ exome
AF:
0.374
Gnomad EAS exome
AF:
0.153
Gnomad FIN exome
AF:
0.447
Gnomad NFE exome
AF:
0.326
Gnomad OTH exome
AF:
0.332
GnomAD4 exome
AF:
0.338
AC:
494159
AN:
1461010
Hom.:
89321
Cov.:
71
AF XY:
0.337
AC XY:
245156
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.786
AC:
26302
AN:
33464
American (AMR)
AF:
0.205
AC:
9141
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.373
AC:
9748
AN:
26114
East Asian (EAS)
AF:
0.126
AC:
5008
AN:
39694
South Asian (SAS)
AF:
0.366
AC:
31552
AN:
86152
European-Finnish (FIN)
AF:
0.442
AC:
23508
AN:
53162
Middle Eastern (MID)
AF:
0.310
AC:
1786
AN:
5766
European-Non Finnish (NFE)
AF:
0.329
AC:
365386
AN:
1111664
Other (OTH)
AF:
0.360
AC:
21728
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
22806
45612
68419
91225
114031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11900
23800
35700
47600
59500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.449
AC:
68259
AN:
151858
Hom.:
18533
Cov.:
31
AF XY:
0.447
AC XY:
33178
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.766
AC:
31738
AN:
41418
American (AMR)
AF:
0.265
AC:
4051
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.382
AC:
1324
AN:
3464
East Asian (EAS)
AF:
0.160
AC:
824
AN:
5146
South Asian (SAS)
AF:
0.360
AC:
1727
AN:
4802
European-Finnish (FIN)
AF:
0.455
AC:
4799
AN:
10556
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.332
AC:
22534
AN:
67882
Other (OTH)
AF:
0.394
AC:
833
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1598
3195
4793
6390
7988
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.349
Hom.:
17442
Bravo
AF:
0.446
Asia WGS
AF:
0.318
AC:
1111
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jan 27, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epidermolysis bullosa dystrophica Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.20
DANN
Benign
0.50
PhyloP100
-1.6
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2255532; hg19: chr3-48624611; COSMIC: COSV60393071; COSMIC: COSV60393071; API